Search research articles
Contact Us
Filters
Showing results (331-340 of 359) with videos related to
Page
of 36
Sort By:
Journal of Neurology
|
October 13, 2001
Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation
M Sciacco, A Prelle, G P Comi, et al.
Annals of the Rheumatic Diseases
|
May 1, 2008
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis
V Liakouli, M Manetti, A Pacini, et al.
Cell
|
February 18, 2014
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors
Diego O Croci, Juan P Cerliani, Tomas Dalotto-Moreno, et al.
Nature Genetics
|
June 30, 2001
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria
J N Spelbrink, F Y Li, V Tiranti, et al.
Journal of Neurology
|
July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa
T Mongini, G Gadaleta, P Alonge, et al.
Neuromuscular Disorders : NMD
|
June 26, 2012
Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency
M Pane, S Messina, G Vasco, et al.
Neuropathology and Applied Neurobiology
|
June 3, 2017
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)
M Ripolone, R Violano, D Ronchi, et al.
The Journal of Organic Chemistry
|
July 2, 2021
Effect of the n<sub>O</sub> → π*<sub>C═O</sub> Interaction on the Conformational Preference of 1,3-Diketones: A Case Study of Riolozatrione Derivatives
Juan F Tamez-Fernández, Fátima M Soto-Suárez, Yolanda D Estrada-Chavarría, et al.
Journal of Neurology
|
November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years
C Angelini, C Semplicini, S Ravaglia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 19, 2015
LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population
O Musumeci, G la Marca, M Spada, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 359) with videos related to
Sort By:
Page
of 36
Journal of Neurology
|
October 13, 2001
Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation
M Sciacco, A Prelle, G P Comi, et al.
Annals of the Rheumatic Diseases
|
May 1, 2008
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis
V Liakouli, M Manetti, A Pacini, et al.
Cell
|
February 18, 2014
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors
Diego O Croci, Juan P Cerliani, Tomas Dalotto-Moreno, et al.
Nature Genetics
|
June 30, 2001
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria
J N Spelbrink, F Y Li, V Tiranti, et al.
Journal of Neurology
|
July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa
T Mongini, G Gadaleta, P Alonge, et al.
Neuromuscular Disorders : NMD
|
June 26, 2012
Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency
M Pane, S Messina, G Vasco, et al.
Neuropathology and Applied Neurobiology
|
June 3, 2017
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)
M Ripolone, R Violano, D Ronchi, et al.
The Journal of Organic Chemistry
|
July 2, 2021
Effect of the n<sub>O</sub> → π*<sub>C═O</sub> Interaction on the Conformational Preference of 1,3-Diketones: A Case Study of Riolozatrione Derivatives
Juan F Tamez-Fernández, Fátima M Soto-Suárez, Yolanda D Estrada-Chavarría, et al.
Journal of Neurology
|
November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years
C Angelini, C Semplicini, S Ravaglia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 19, 2015
LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population
O Musumeci, G la Marca, M Spada, et al.
Page
of 36